Publicacións (19) Publicacións de Manuel Collado Rodríguez

filter_list Cancer Research

2024

  1. Inhibition of lung tumorigenesis by transient reprogramming in cancer cells

    Cell Death and Disease, Vol. 15, Núm. 11

2023

  1. Epigenetic reprogramming of a distal developmental enhancer cluster drives SOX2 overexpression in breast and lung adenocarcinoma

    Nucleic acids research, Vol. 51, Núm. 19, pp. 10109-10131

2022

  1. SOX9 Triggers Different Epithelial to Mesenchymal Transition States to Promote Pancreatic Cancer Progression

    Cancers, Vol. 14, Núm. 4

2021

  1. RANK links senescence to stemness in the mammary epithelia, delaying tumor onset but increasing tumor aggressiveness

    Developmental Cell, Vol. 56, Núm. 12, pp. 1727-1741.e7

  2. SUMOylation modulates the stability and function of PI3K-p110β

    Cellular and Molecular Life Sciences, Vol. 78, Núm. 8, pp. 4053-4065

  3. The Jekyll and Hyde of Senescence in Cancer: TIMP1 Controls the Switch from Tumor-Controlling to Tumor-Promoting Senescence

    Cancer Cell, Vol. 39, Núm. 1, pp. 13-15

  4. Tumor microenvironment in metastatic colorectal cancer: The arbitrator in patients’ outcome

    Cancers, Vol. 13, Núm. 5, pp. 1-29

2020

  1. Senotherapy of Cancer

    SENOLYTICS IN DISEASE, AGEING AND LONGEVITY (SPRINGER INTERNATIONAL PUBLISHING AG), pp. 85-99

2019

  1. Context-Dependent Impact of RAS Oncogene Expression on Cellular Reprogramming to Pluripotency

    Stem Cell Reports, Vol. 12, Núm. 5, pp. 1099-1112

2015

  1. Transcriptional regulation of Sox2 by the retinoblastoma family of pocket proteins

    Oncotarget, Vol. 6, Núm. 5, pp. 2992-3002

2014

  1. Tumour-infiltrating Gr-1 + myeloid cells antagonize senescence in cancer

    Nature, Vol. 515, Núm. 7525, pp. 134-137

2012

  1. Oncogenicity of the developmental transcription factor Sox9

    Cancer Research, Vol. 72, Núm. 5, pp. 1301-1315

2009

  1. Histone macroH2A isoforms predict the risk of lung cancer recurrence

    Oncogene, Vol. 28, Núm. 38, pp. 3423-3428

  2. Limited role of murine ATM in oncogene-induced senescence and p53-dependent tumor suppression

    PLoS ONE, Vol. 4, Núm. 5

  3. WNT16B is a new marker of cellular senescence that regulates p53 activity and the phosphoinositide 3-kinase/AKT pathway

    Cancer Research, Vol. 69, Núm. 24, pp. 9183-9191

2007

  1. Cellular Senescence in Cancer and Aging

    Cell, Vol. 130, Núm. 2, pp. 223-233

  2. Inactivation of the candidate tumor suppressor Par-4 in endometrial cancer

    Cancer Research, Vol. 67, Núm. 5, pp. 1927-1934

2004

  1. Different cooperating effect of p21 or p27 deficiency in combination with INK4a/ARF deletion in mice

    Oncogene, Vol. 23, Núm. 50, pp. 8231-8237

2001

  1. BCR-ABL-expressing cells transduced with the HSV-tk gene die by apoptosis upon treatment with ganciclovir

    Molecular Therapy, Vol. 3, Núm. 5, pp. 642-652